Tokyo Tape
Sign in
← Cytori Cell Research Institute

Quarterly report · Q1

3750.TEDINET S100RO02
Period2023-04-01 → 2023-06-30
Filed2023-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥472m2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥2.1bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥544m2022-04-01 → 2022-06-30Cons.Net sales
Operating income−¥137m2023-04-01 → 2023-06-30Cons.Operating income
Operating income−¥163m2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income−¥169m2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income−¥862m2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥186m2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax−¥166m2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax−¥294m2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)−¥161m2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥1.1bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥288m2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income−¥161m2023-04-01 → 2023-06-30Cons.Profit loss
Net income−¥288m2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥13.9bnat 2023-06-30Cons.Assets
Total assets¥14.1bnat 2023-03-31Cons.Assets
Total assets¥14.5bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥11.4bnat 2023-06-30Cons.Liabilities
Total liabilities¥11.4bnat 2023-03-31Cons.Liabilities
Net assets / equity¥2.5bnat 2023-06-30Cons.Net assets
Net assets / equity¥2.7bnat 2023-03-31Cons.Net assets
Net assets / equity¥3.4bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥887mat 2023-06-30Cons.Cash and deposits
Cash and deposits¥1.1bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥-18.072023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-118.712022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-32.212022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio16.5%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio17.3%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio22.1%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-06-30−¥41m
jpcrp040300-q1r_E05443-000Medical Asset Managemetreportable segmentrevenue2023-04-01 → 2023-06-30¥26m
jpcrp040300-q1r_E05443-000Medical Asset Managemetreportable segmentrevenue external2023-04-01 → 2023-06-30¥26m
jpcrp040300-q1r_E05443-000Medical Asset Managemetreportable segmentsegment profit2023-04-01 → 2023-06-30−¥157m
jpcrp040300-q1r_E05443-000Real Asset Managementreportable segmentrevenue2023-04-01 → 2023-06-30¥446m
jpcrp040300-q1r_E05443-000Real Asset Managementreportable segmentrevenue external2023-04-01 → 2023-06-30¥446m
jpcrp040300-q1r_E05443-000Real Asset Managementreportable segmentsegment profit2023-04-01 → 2023-06-30¥62m
—segment totalrevenue2023-04-01 → 2023-06-30¥472m
—segment totalrevenue external2023-04-01 → 2023-06-30¥472m
—segment totalsegment profit2023-04-01 → 2023-06-30−¥96m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-06-30−¥38m
jpcrp040300-q1r_E05443-000Medical Asset Managemetreportable segmentrevenue2022-04-01 → 2022-06-30¥37m
jpcrp040300-q1r_E05443-000Medical Asset Managemetreportable segmentrevenue external2022-04-01 → 2022-06-30¥37m
jpcrp040300-q1r_E05443-000Medical Asset Managemetreportable segmentsegment profit2022-04-01 → 2022-06-30−¥47m
jpcrp040300-q1r_E05443-000Real Asset Managementreportable segmentrevenue2022-04-01 → 2022-06-30¥507m
jpcrp040300-q1r_E05443-000Real Asset Managementreportable segmentrevenue external2022-04-01 → 2022-06-30¥507m
jpcrp040300-q1r_E05443-000Real Asset Managementreportable segmentsegment profit2022-04-01 → 2022-06-30−¥78m
—segment totalrevenue2022-04-01 → 2022-06-30¥544m
—segment totalrevenue external2022-04-01 → 2022-06-30¥544m
—segment totalsegment profit2022-04-01 → 2022-06-30−¥125m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 312
ItemContextValueUnit
Noncurrent liabilitiesPrior1YearInstant10261328000JPY
Noncurrent liabilitiesCurrentQuarterInstant10151055000JPY
LiabilitiesPrior1YearInstant11434953000JPY
LiabilitiesCurrentQuarterInstant11359804000JPY
Capital stockPrior1YearInstant100000000JPY
Capital stockCurrentQuarterInstant100000000JPY
Capital surplusPrior1YearInstant2939268000JPY
Capital surplusCurrentQuarterInstant2939268000JPY
Retained earningsPrior1YearInstant-596921000JPY
Retained earningsCurrentQuarterInstant-758214000JPY
Treasury stockPrior1YearInstant-1240000JPY
Treasury stockCurrentQuarterInstant-1296000JPY
Shareholders equityPrior1YearInstant2441106000JPY
Shareholders equityCurrentQuarterInstant2279757000JPY
Valuation difference on available for sale securitiesPrior1YearInstant66000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant97000JPY
Valuation and translation adjustmentsPrior1YearInstant66000JPY
Valuation and translation adjustmentsCurrentQuarterInstant97000JPY
Subscription rights to sharesPrior1YearInstant211501000JPY
Subscription rights to sharesCurrentQuarterInstant211501000JPY
Non controlling interestsPrior1YearInstant4007000JPY
Non controlling interestsCurrentQuarterInstant4036000JPY
Net assetsPrior1YearInstant2656682000JPY
Net assetsCurrentQuarterInstant2495393000JPY
Liabilities and net assetsPrior1YearInstant14091635000JPY
Liabilities and net assetsCurrentQuarterInstant13855197000JPY
Net salesPrior1YTDDuration543539000JPY
Net salesCurrentYTDDuration472475000JPY
Cost of salesPrior1YTDDuration261363000JPY
Cost of salesCurrentYTDDuration71383000JPY
Gross profitPrior1YTDDuration282175000JPY
Gross profitCurrentYTDDuration401092000JPY
Selling general and administrative expensesPrior1YTDDuration444713000JPY
Selling general and administrative expensesCurrentYTDDuration538222000JPY
Operating incomePrior1YTDDuration-162537000JPY
Operating incomeCurrentYTDDuration-137130000JPY
Subsidy income noi bountyPrior1YTDDuration22499000JPY
Subsidy income noi bountyCurrentYTDDuration－JPY
Other noiPrior1YTDDuration5573000JPY
Other noiCurrentYTDDuration6801000JPY
Non operating incomePrior1YTDDuration28073000JPY
Non operating incomeCurrentYTDDuration6801000JPY
Interest expenses noePrior1YTDDuration26694000JPY
Interest expenses noeCurrentYTDDuration38830000JPY
Arrangement fee noePrior1YTDDuration25000000JPY
Arrangement fee noeCurrentYTDDuration－JPY
Other noePrior1YTDDuration6000JPY
Other noeCurrentYTDDuration13000JPY
Non operating expensesPrior1YTDDuration51701000JPY
Non operating expensesCurrentYTDDuration38844000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass